v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 27, 2024
Sep. 29, 2023
Statement of Cash Flows [Abstract]    
Net income $ 381,406 $ 122,247
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 21,161 19,191
Impairment of long-lived assets 64,238 0
Stock-based compensation 67,490 82,039
Non-cash lease expense 21,111 21,475
Acquired in-process research and development technology 31,250 128,500
Other, net (9,247) (12,372)
Changes in operating assets and liabilities:    
Trade receivables, net (32,192) (33,804)
Inventory 2,691 (14,503)
Prepaid expenses and other assets (63,068) 2,430
Accrued collaboration liabilities (1,003) 1,081
Accounts payable and other liabilities (24,129) 6,469
Net cash provided by operating activities 459,708 322,753
Cash flows from investing activities:    
Purchases of marketable securities (622,522) (823,847)
Proceeds from maturities and sales of marketable securities 651,148 884,989
Purchases of property, equipment and other, net (24,458) (27,334)
Acquired in-process research and development technology (27,750) (122,500)
Net cash used in investing activities (23,582) (88,692)
Cash flows from financing activities:    
Payments for repurchases of common stock (461,621) (341,082)
Proceeds from issuance of common stock under the equity incentive plan and stock purchase plan 43,027 24,339
Taxes paid related to net share settlement of equity awards (22,180) (23,136)
Net cash used in financing activities (440,774) (339,879)
Net decrease in cash and cash equivalents (4,648) (105,818)
Cash and cash equivalents at beginning of period 262,994 502,677
Cash and cash equivalents at end of period 258,346 396,859
Non-cash operating activities:    
Right-of-use assets obtained in exchange for lease obligations $ 15,313 $ 13,612